anti-Human IL5 antibody for Blocking Antibody

Recommended IL5 Antibody (supplied by: Log in to see )

Antigen
Interleukin 5 (IL5) Antibodies
  • EDF
  • IL-5
  • TRF
  • Il-5
  • IL5
  • interleukin 5
  • IL5
  • Il5
Reactivity
Human
190
137
27
20
17
3
2
2
1
1
1
Host
Rat
121
102
31
2
Clonality
Monoclonal
Conjugate
This IL5 antibody is un-conjugated
38
14
7
7
6
6
6
5
5
5
3
3
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
Application
Blocking Antibody (Inhibition), ELISA, Western Blotting (WB)
124
123
107
23
23
13
11
10
10
9
9
7
6
6
5
4
4
4
2
2
1
1
Options
Supplier
Log in to see
Supplier Product No.
Log in to see
Request

Get this product for free

Submit your validation data for this product and get a full refund. I want to validate this product

Learn more

Catalog No. ABIN2689771
Contact our Customer Service for availability and price in your country.
Relevance Score ABIN Application Conjugate Host Isotype Epitope Supplier Clonality References Details
1 ABIN2689772 Inhibition ELISA WB Rat IgG1, kappa Log in to see TRFK5 8
1 ABIN1002650 Inhibition ELISA WB Rabbit IgG Log in to see Polyclonal
1 ABIN289348 Inhibition ELISA WB Rabbit Log in to see Polyclonal
1 ABIN2689773 Inhibition Neut ELISA WB Rat IgG1, kappa Log in to see TRFK5
1 ABIN636668 Inhibition ELISA WB Rabbit Log in to see Polyclonal

General

Antigen Interleukin 5 (IL5) Antibodies
Reactivity Human
(190), (137), (27), (20), (17), (3), (2), (2), (1), (1), (1)
Host Rat
(121), (102), (31), (2)
Clonality (Clone)
Monoclonal   ( )
Conjugate This IL5 antibody is un-conjugated
(38), (14), (7), (7), (6), (6), (6), (5), (5), (5), (3), (3), (2), (2), (2), (2), (2), (2), (2), (1), (1), (1), (1), (1), (1), (1), (1), (1)
Application Blocking Antibody (Inhibition), ELISA, Western Blotting (WB)
(124), (123), (107), (23), (23), (13), (11), (10), (10), (9), (9), (7), (6), (6), (5), (4), (4), (4), (2), (2), (1), (1)
Pubmed 5 references available
Supplier Log in to see

Product Details anti-IL5 Antibody

Target Details IL5 Application Details Handling References for anti-IL5 antibody (ABIN2689771) Images
Brand BD Pharmingen™
Characteristics The JES1-39D10 antibody reacts with human interleukin-5 (IL-5). The immunogen used to generate the JES1-39D10 hybridoma was COS-expressed recombinant human IL-5. This is a neutralizing antibody. This antibody is routinely tested by ELISA. Other applications were tested during antibody development only or reported in the literature.

BD Pharmingen™ Purified Rat Anti-Human IL-5 - Purified - Clone JES1-39D10 - Isotype Rat IgG2a - Reactivity Hu - 0.5 mg
Purification The monoclonal antibody was purified from tissue culture supernatant or ascites by affinity chromatography.
Immunogen Recombinant human IL-5
Clone JES1
Isotype IgG2a

Target Details IL5

Product Details anti-IL5 Antibody Application Details Handling References for anti-IL5 antibody (ABIN2689771) Images back to top
Antigen
Alternative Name IL-5 (IL5 Antibody Abstract)
Research Area Cytokines, Immunology, Virology, Inflammation, Cancer
Pathways JAK-STAT Signaling, Positive Regulation of Peptide Hormone Secretion, Production of Molecular Mediator of Immune Response, Feeding Behaviour

Application Details

Product Details anti-IL5 Antibody Target Details IL5 Handling References for anti-IL5 antibody (ABIN2689771) Images back to top
Application Notes Optimal working dilution should be determined by the investigator.
Restrictions For Research Use only

Handling

Product Details anti-IL5 Antibody Target Details IL5 Application Details References for anti-IL5 antibody (ABIN2689771) Images back to top
Concentration 0.5 mg/mL
Buffer Aqueous buffered solution containing ≤0.09 % sodium azide.
Preservative Sodium azide
Precaution of Use This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Storage 4 °C
Storage Comment Store undiluted at 4°C.

References for anti-IL5 antibody (ABIN2689771)

Product Details anti-IL5 Antibody Target Details IL5 Application Details Handling Images back to top
Product cited in:

Prussin, Metcalfe: "Detection of intracytoplasmic cytokine using flow cytometry and directly conjugated anti-cytokine antibodies." in: Journal of immunological methods, Vol. 188, Issue 1, pp. 117-28, 1996

Jung, Schauer, Rieger, Wagner, Einsle, Neumann, Heusser: "Interleukin-4 and interleukin-5 are rarely co-expressed by human T cells." in: European journal of immunology, Vol. 25, Issue 8, pp. 2413-6, 1995

Abrams, Roncarolo, Yssel, Andersson, Gleich, Silver: "Strategies of anti-cytokine monoclonal antibody development: immunoassay of IL-10 and IL-5 in clinical samples." in: Immunological reviews, Vol. 127, Issue 9-10, pp. 5-24, 1992

Butterfield, Leiferman, Abrams, Silver, Bower, Gonchoroff, Gleich: "Elevated serum levels of interleukin-5 in patients with the syndrome of episodic angioedema and eosinophilia." in: Blood, Vol. 79, Issue 3, pp. 688-92, 1992

Limaye, Abrams, Silver, Awadzi, Francis, Ottesen, Nutman: "Interleukin-5 and the posttreatment eosinophilia in patients with onchocerciasis." in: The Journal of clinical investigation, Vol. 88, Issue 4, pp. 1418-21, 1991